... usually based on revenue and EBITDA growth, as well as customer base characteristics and brand awareness. For investors, clear financial indicators are crucial: currency revenue, profitability, debt burden, and resilience of the business model amid macroeconomic ... ... pharmaceutical assets. Another example is “Ozon Pharmaceuticals”—a generic manufacturer from the Samara region—that announced IPO plans for the fall of 2024. In the narrower biotech segment, companies like “Betuvax” (vaccine “Betuvax-CoV-2”) and “Promomed” ...

... news. An unexpected event – whether a major DeFi protocol hack on Cardano, lawsuits against associated companies, or global financial shocks – could instantly alter price dynamics. Given all the above, investors should exercise caution. The forecast ... ... modestly if market conditions remain favorable. Simultaneously, the flip side – volatility and risks – could correct these plans. Ultimately, Cardano's prospects for May 2025 seem positive from the perspective of project development and ADA analytics,...